ATE68346T1 - Feuchtigkeitsstabile feste valproinsaeurezubereitung und verfahren zu ihrer herstellung. - Google Patents

Feuchtigkeitsstabile feste valproinsaeurezubereitung und verfahren zu ihrer herstellung.

Info

Publication number
ATE68346T1
ATE68346T1 AT87810611T AT87810611T ATE68346T1 AT E68346 T1 ATE68346 T1 AT E68346T1 AT 87810611 T AT87810611 T AT 87810611T AT 87810611 T AT87810611 T AT 87810611T AT E68346 T1 ATE68346 T1 AT E68346T1
Authority
AT
Austria
Prior art keywords
weight percent
valproic acid
moisture
stable solid
production
Prior art date
Application number
AT87810611T
Other languages
English (en)
Inventor
Aracelis M Dr Ortega
Perez Pilar Martin Dr De
Margarita De
Original Assignee
Farvalsa Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farvalsa Ag filed Critical Farvalsa Ag
Application granted granted Critical
Publication of ATE68346T1 publication Critical patent/ATE68346T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2009Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT87810611T 1987-07-22 1987-10-23 Feuchtigkeitsstabile feste valproinsaeurezubereitung und verfahren zu ihrer herstellung. ATE68346T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7663487A 1987-07-22 1987-07-22
EP87810611A EP0300111B1 (de) 1987-07-22 1987-10-23 Feuchtigkeitsstabile feste Valproinsäure-Zubereitung und Verfahren zu ihrer Herstellung

Publications (1)

Publication Number Publication Date
ATE68346T1 true ATE68346T1 (de) 1991-11-15

Family

ID=22133265

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87810611T ATE68346T1 (de) 1987-07-22 1987-10-23 Feuchtigkeitsstabile feste valproinsaeurezubereitung und verfahren zu ihrer herstellung.

Country Status (6)

Country Link
US (1) US5049586A (de)
EP (1) EP0300111B1 (de)
AT (1) ATE68346T1 (de)
DE (1) DE3773926D1 (de)
ES (1) ES2026198T3 (de)
GR (1) GR3003187T3 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1002098B (en) * 1989-06-08 1995-12-28 Squibb & Sons Inc Pharmaceutical composition having good stability
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
MY110880A (en) * 1991-01-30 1999-06-30 The Wellcome Foundation Ltd Water-dispersible tablets
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
US20040191314A1 (en) * 1994-04-28 2004-09-30 Frank Jao Antiepileptic dosage form and process for protecting antiepileptic drug
ZA953078B (en) * 1994-04-28 1996-01-05 Alza Corp Effective therapy for epilepsies
US5681854A (en) * 1995-11-22 1997-10-28 Alcon Laboratories, Inc. Use of aliphatic carboxylic acid derivatives in ophthalmic disorders
CN1063971C (zh) * 1997-09-24 2001-04-04 中国兽药监察所 一种动物用冻干活疫苗制造方法
US6300328B1 (en) 1999-08-06 2001-10-09 Alcon Universal Ltd. Selective inhibitors of adenosine monophosphate deaminase for the treatment of optic nerve and retinal damage
BR0016415A (pt) * 1999-12-16 2002-12-24 Alcon Inc Inibidores de adenosina cinase para o tratamento de dano retinal e de nervo ótico
US20020143058A1 (en) 2001-01-24 2002-10-03 Taro Pharmaceutical Inductries Ltd. Process for preparing non-hygroscopic sodium valproate composition
US6610326B2 (en) * 2001-02-16 2003-08-26 Andrx Corporation Divalproex sodium tablets
US20040105886A1 (en) * 2001-02-16 2004-06-03 Chih-Ming Chen Divalproex sodium tablets
NZ540288A (en) 2002-11-22 2009-06-26 Univ Johns Hopkins Target for therapy of cognitive impairment
MXPA05005937A (es) 2002-12-06 2005-08-18 Alcon Inc Imitaciones de superoxido de dismutasa para el tratamiento de trastornos y enfermedades oculares.
US20040176463A1 (en) * 2003-02-05 2004-09-09 Daniella Licht Immediate release formulation of n-(2-propylpentanoyl)glycinamide
MXPA06006187A (es) * 2003-12-11 2006-08-25 Alcon Inc Imitadores de super oxido dismutasa para el tratamiento de dano retinal y de nervio optico.
US20050276849A1 (en) * 2004-06-15 2005-12-15 Nilobon Podhipleux Sustained release dosage forms
US7713550B2 (en) * 2004-06-15 2010-05-11 Andrx Corporation Controlled release sodium valproate formulation
US20070048379A1 (en) * 2005-08-29 2007-03-01 Mintong Guo Valproate tablet
JP2009525953A (ja) * 2006-01-11 2009-07-16 テバ ファーマシューティカル インダストリーズ リミティド ジバルプロ酸及びその誘導体の徐放性製剤
DE602006003848D1 (de) * 2006-01-11 2009-01-08 Teva Pharma Formulierung zur verzögerten Freisetzung von Valproinsäure und deren Derivate
US20070160667A1 (en) * 2006-01-11 2007-07-12 Nava Shterman Controlled release formulation of divalproex sodium
US7625927B2 (en) * 2006-02-27 2009-12-01 Alcon Research, Ltd. Method of treating glaucoma
WO2008001151A1 (en) * 2006-06-29 2008-01-03 Wockhardt Limited Controlled release compositions of divalproex sodium
US20110203586A1 (en) * 2008-02-20 2011-08-25 Boehringer Ingelheim International Gmbh Powder Inhalers
US20090235929A1 (en) * 2008-03-19 2009-09-24 Marc Egen Powder inhalers
ES2865504T3 (es) 2008-10-16 2021-10-15 Univ Johns Hopkins Procedimientos y composiciones para la mejora de la función cognitiva
AU2011215870B2 (en) * 2010-02-09 2016-01-28 The Johns Hopkins University Methods and compositions for improving cognitive function
DK2683371T3 (da) * 2011-03-09 2021-01-18 Cereno Scient Ab Forbindelser og fremgangsmåder til forbedring af forringet endogen fibrinolyse ved anvendelse af histondeacetylasehæmmere
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
WO2014144663A1 (en) 2013-03-15 2014-09-18 The Johns Hopkins University Methods and compositions for improving cognitive function
JP6433482B2 (ja) 2013-03-15 2018-12-05 エージンバイオ, インコーポレイテッド 認知機能を改善するための方法および組成物
GB201417828D0 (en) 2014-10-08 2014-11-19 Cereno Scient Ab New methods and compositions
WO2016191288A1 (en) 2015-05-22 2016-12-01 Agenebio, Inc. Extended release pharmaceutical compositions of levetiracetam
CA3018043A1 (en) 2016-04-08 2017-10-12 Cereno Scientific Ab Delayed release pharmaceutical formulations comprising valproic acid, and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL32673A (en) * 1968-08-05 1973-11-28 Ciba Geigy Ag A granular material containing oily or liquid therapeutically usable furanosides and a process for its manufacture
US4301176A (en) * 1980-08-18 1981-11-17 Warner-Lambert Company Method of administering calcium valproate
NL8600050A (nl) * 1986-01-13 1987-08-03 Sanico Nv Farmaceutisch preparaat met vertraagde afgifte van het werkzame bestanddeel en werkwijze voor de bereiding er van.

Also Published As

Publication number Publication date
ES2026198T3 (es) 1992-04-16
GR3003187T3 (en) 1993-02-17
EP0300111B1 (de) 1991-10-16
EP0300111A1 (de) 1989-01-25
US5049586A (en) 1991-09-17
DE3773926D1 (de) 1991-11-21

Similar Documents

Publication Publication Date Title
ATE68346T1 (de) Feuchtigkeitsstabile feste valproinsaeurezubereitung und verfahren zu ihrer herstellung.
HUT49358A (en) Process for producing phosphorous compounds, pharmaceutical compositions comprising same as active ingredient and intermediaries
GB2143734B (en) Process for the preparation of sustained release pharmaceutical compositions having a high active ingredient content
ATE48943T1 (de) Feste arzneizubereitung enthaltend nitrendipin und verfahren zur ihrer herstellung.
HUT47552A (en) Process for producing 10-dihydro-10-deoxo-11-aza-erythronolid a derivatives and pharmaceutical compositions containing them as active components
PH25376A (en) Oral sustained release acetaminophen formulation, process
HUT61989A (en) Process for producing 2-deoxy-2,3-didehydro-n-acetylneuraminic acid derivatives and analogs, as well as pharmaceutical compositions comprising same as active ingredient
HUT50467A (en) Process for producing 7-/1-azetidinyl/-1,4-dihydro-4-oxo-3-quinoline-carboxylic acid derivatives and pharmaceutical compositions containing them as active components
HUT51485A (en) Process for production of immune-hindering, monoquin, especially internuclein-1-hindering medical compositions
IL88615A (en) 1,7-annelated indolecarboxylic acid esters and carboxamides,their preparation and pharmaceutical compositions containing them
GB1296505A (de)
HUT52952A (en) Process for producing long-acting gemfibrosyl compositions
HUT48902A (en) Process for producing new ribofuranuronic acid derivatives and pharmaceutical compositions containing them
HUT48597A (en) Process for producing pharmaceutical compositions comprising substituted 2-phenyl-4-quinolinecarboxylic acid derivatives and the new quinolinecarboxylic acid derivatives
HUT50112A (en) Process for producing phenoxyalkyl-carboxylic acid derivatives and pharmaceutical compositions containing them as active component
DE3274185D1 (en) Medicinal preparations for glycoside-hydrolase inhibitors
HUT49361A (en) Process for producing piperazinecarboxylic acid derivative and pharmaceutical compositions comprising this compound
IL87876A0 (en) Catechol carboxylic acid derivatives,their preparation and pharmaceutical compositions containing them
HUT54166A (en) Process for producing 1,1-dioxocefem-4-carbothiol acid derivatives and pharmaceutical compositions comprising same as active ingredient
IL87130A0 (en) Hydrocinnamic acid derivatives,their manufacture and pharmaceutical compositions containing them
HUT48613A (en) Process for producing carbamoyloxylabdane derivatives, their intermediaries and pharmaceutical compositions comprising such compounds as active ingredient
DE59010710D1 (de) Modifizierte Stärke und Verfahren zu ihrer Herstellung
HUT50324A (en) Process for producing thiophene-2-carboxylic acid derivatives and pharmaceutical compositions comprising such compounds
ZA893330B (en) Process for preparing bodies containing a peroxy acid compound and compositions comprising said bodies
EP0383481A3 (de) Bukkale Anästhetika

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee